These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31713241)

  • 1. Is Placebo Response Responsible for Many Phase III Failures?
    Dumitrescu TP; McCune J; Schmith V
    Clin Pharmacol Ther; 2019 Dec; 106(6):1151-1154. PubMed ID: 31713241
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversy trails adaptive clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(18):1347-8. PubMed ID: 22984199
    [No Abstract]   [Full Text] [Related]  

  • 4. A pilot seminar on ethical issues in clinical trials for cancer researchers in Vietnam.
    Love RR; Fost N
    IRB; 2003; 25(6):8-10. PubMed ID: 15035249
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-Placebo Additivity in Randomized Clinical Trials.
    Hall KT; Loscalzo J
    Clin Pharmacol Ther; 2019 Dec; 106(6):1191-1197. PubMed ID: 31502253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are medication-free periods necessary for phase 3 trials of new antipsychotic drugs?
    Volavka J
    Arch Gen Psychiatry; 1998 Mar; 55(3):280-1; 283. PubMed ID: 9510226
    [No Abstract]   [Full Text] [Related]  

  • 7. How does a drug get to phase III trials?
    Reynolds T
    J Natl Cancer Inst; 2000 Oct; 92(19):1555. PubMed ID: 11018084
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial research in focus: why do so many clinical trials fail in IPF?
    Spagnolo P; Maher TM
    Lancet Respir Med; 2017 May; 5(5):372-374. PubMed ID: 28412184
    [No Abstract]   [Full Text] [Related]  

  • 9. New scale assesses benefits of cancer medicines.
    Bagcchi S
    Lancet Oncol; 2015 Jul; 16(7):e316. PubMed ID: 26051234
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients in test won't get drug, Amgen decides.
    Pollack A
    N Y Times Web; 2005 Feb; ():C1, C2. PubMed ID: 15742509
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel treatments for castration-resistant prostate cancer.
    Sternberg CN
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S195-9. PubMed ID: 21943975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated drug development through combined phase 2/3 clinical trial design.
    Cunningham ET; da Silva L; Harrison EM; Modi MW; O'Shaughnessy D; Guyer DR
    Arch Ophthalmol; 2004 Jul; 122(7):1043-4. PubMed ID: 15249371
    [No Abstract]   [Full Text] [Related]  

  • 13. General issues and precautions in the design for clinical trials of investigational new drugs.
    Hu LP; Bao XL
    Zhong Xi Yi Jie He Xue Bao; 2011 Feb; 9(2):138-42. PubMed ID: 21288447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Market watch: Upcoming market catalysts in Q1 2017.
    Fulton Z
    Nat Rev Drug Discov; 2016 Dec; 16(1):11. PubMed ID: 28031567
    [No Abstract]   [Full Text] [Related]  

  • 15. Design of phase II trials in congestive heart failure.
    DeMets DL
    Am Heart J; 2000 Apr; 139(4):S207-10. PubMed ID: 10740134
    [No Abstract]   [Full Text] [Related]  

  • 16. Digestive Disease Week 2005. Drug highlights II.
    De La Rue SA
    IDrugs; 2005 Jul; 8(7):539-41. PubMed ID: 15973558
    [No Abstract]   [Full Text] [Related]  

  • 17. Market watch: Upcoming market catalysts in Q1 2014.
    Stopke E
    Nat Rev Drug Discov; 2014 Jan; 13(1):11. PubMed ID: 24378790
    [No Abstract]   [Full Text] [Related]  

  • 18. Current perspectives on the design of phase II trials of new drugs for the treatment of heart failure.
    Packer M
    Am Heart J; 2000 Apr; 139(4):S202-6. PubMed ID: 10740133
    [No Abstract]   [Full Text] [Related]  

  • 19. Are placebo-controlled studies required in order to prove efficacy of antidepressants?
    Möller HJ
    World J Biol Psychiatry; 2005; 6(3):130-1. PubMed ID: 16166027
    [No Abstract]   [Full Text] [Related]  

  • 20. SOP 09: Statistical design and analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():43-7. PubMed ID: 23570186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.